HuGE Literature Finder
Records
1
-
30
| Causal associations between gastroesophageal reflux disease and lung cancer risk: A Mendelian randomization study. Cancer medicine 2022 Dec . Li Lin, Ren Qiaoya, Zheng Qian, Bai Yuju, He Sisi, Zhang Yu, Ma |
| Impact of KRAS Mutations on Clinical Outcomes of Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer Receiving Anti-PD-1/PD-L1 Therapy. Targeted oncology 2022 Dec . Veccia Antonello, Dipasquale Mariachiara, Kinspergher Stefania, Monteverdi Sara, Girlando Salvatore, Barbareschi Mattia, Caffo Oraz |
| Risk of thromboembolism in non-small-cell lung cancers patients with different oncogenic drivers, including ROS1, ALK, and EGFR mutations. ESMO open 2022 Dec 7 (6): 100742. Wang H-Y, Wu S-G, Lin Y-T, Chen C-Y, Shih J |
| Uncertain resection of highest mediastinal lymph node positive among pN2 non-small cell lung cancer patients: survival analysis of postoperative radiotherapy and driver gene mutations. Japanese journal of radiology 2022 Dec . Deng Qianyue, Wang Huan, Xiu Weigang, Tian Xiaoman, Gong Youli |
| Concurrent TP53 mutations predict a poor prognosis of EGFR-mutant NSCLCs treated with TKIs: An updated systematic review and meta-analysis. Oncology letters 2022 Nov 24 (5): 384. Lan Bo, Zhao Na, Du Kang, Leng Baola |
| A large-scale prospective concordance study of plasma- and tissue-based next-generation targeted sequencing for advanced non-small cell lung cancer (LC-SCRUM-Liquid). Clinical cancer research : an official journal of the American Association for Cancer Research 2022 Oct . Sugimoto Akira, Matsumoto Shingo, Udagawa Hibiki, Itotani Ryo, Usui Yuko, Umemura Shigeki, Nishino Kazumi, Nakachi Ichiro, Kuyama Shoichi, Daga Haruko, Hara Satoshi, Miyamoto Shingo, Kato Terufumi, Sakakibara-Konishi Jun, Tabata Eriko, Nakagawa Taku, Kawaguchi Tomoya, Sakai Tetsuya, Shibata Yuji, Izumi Hiroki, Nosaki Kaname, Zenke Yoshitaka, Yoh Kiyotaka, Goto Koic |
| Age does matter in adolescents and young adults vs. older adults with lung adenocarcinoma: A retrospective analysis comparing clinical characteristics and outcomes in response to systematic treatments. Oncology letters 2022 Oct 24 (4): 362. Zhou Lin, Li Huiwu, Yang Shuh |
| An exploration of LAF-bTMB as a predictor for the efficacy of immunotherapy combined with chemotherapy in non-small cell lung cancer. Thoracic cancer 2022 Oct . Zhang Shuyang, Yang Lu, Yang Yaning, Xin Ying, Wang Y |
| Baseline anemia predicts a poor prognosis in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: a retrospective study. BMC pulmonary medicine 2022 Oct 22 (1): 381. Wei Jingwen, Xiang Jing, Hao Yue, Si Jinfei, Wang Wenxian, Li Fangyin, Song Zheng |
| Comparative study of TNF-? and vitamin D reveals a significant role of TNF-? in NSCLC in an ethnically conserved vitamin D deficient population. Cytokine 2022 Oct 160 156039. Bhat Imtiyaz Ahmed, Mir Ishfaq Rashid, Malik Gawharul Haq, Mir Javid Iqbal, Dar Taief Ahmad, Nisar Syed, Naik Niyaz Ahmad, Sabah Zia-Ul, Shah Zafar Am |
| EGFR Mutation-Positive Unresectable Stage III Non-Squamous Lung Cancer is Associated with a High Incidence of Brain Metastasis. Cancer research and treatment 2022 Oct . Kim Hongsik, Park Sehhoon, Jung Hyun Ae, Sun Jong-Mu, Lee Se-Hoon, Ahn Jin Seok, Ahn Myung- |
| ERBB2 exon 20 insertions are rare in Brazilian non-small cell lung cancer. Thoracic cancer 2022 Oct . de Oliveira Cavagna Rodrigo, Zaniolo Beatriz Garbe, de Paula Flávia Escremim, Berardinelli Gustavo Noriz, Santana Iara, da Silva Eduardo Caetano Albino, Dias Josiane Mourão, Jacinto Alexandre Arthur, da Nóbrega Oliveira Rachid Eduardo Noleto, de Marchi Pedro, Leal Letícia Ferro, Reis Rui Manu |
| Genetic variants in LKB1/AMPK/mTOR pathway are associated with clinical outcomes of chemotherapy in non-small cell lung cancer. Thoracic cancer 2022 Oct . Choi Sun Ha, Do Sook Kyung, Lee Shin Yup, Choi Jin Eun, Kang Hyo-Gyoung, Hong Mi Jeong, Lee Jang Hyuck, Lee Won Kee, Jeong Ji Yun, Shin Kyung Min, Do Young Woo, Lee Eung Bae, Park Ji Eun, Lee Yong Hoon, Seo Hyewon, Yoo Seung Soo, Lee Jaehee, Cha Seung Ick, Kim Chang Ho, Park Jae Yo |
| KIR-HLA gene diversities and susceptibility to lung cancer. Scientific reports 2022 Oct 12 (1): 17237. Hematian Larki Marjan, Ashouri Elham, Barani Shaghik, Ghayumi Seiyed Mohammad Ali, Ghaderi Abbas, Rajalingam Ra |
| PIK3CA mutations associated with a poor postoperative prognosis in patients with pulmonary pleomorphic carcinoma: a retrospective cohort study. BMC cancer 2022 Oct 22 (1): 1066. Kojima Kensuke, Imai Saki, Samejima Hironobu, Fujiwara Ayako, Tokunaga Toshiteru, Yoon Hyungeun, Okishio Kyoic |
| Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer. FEBS open bio 2022 Oct . Xu Fei, Cui Wen-Qiang, Liu Cun, Feng Fubin, Liu Ruijuan, Zhang Jingtao, Sun Chang-Ga |
| Prognostic impact of tumour mutational burden in resected stage I and II lung adenocarcinomas from a European Thoracic Oncology Platform Lungscape cohort. Lung cancer (Amsterdam, Netherlands) 2022 Oct 174 27-35. Bubendorf Lukas, Zoche Martin, Dafni Urania, Rüschoff Jan Hendrik, Prince Spasenija Savic, Marti Nesa, Stavrou Androniki, Kammler Roswitha, Finn Stephen P, Moch Holger, Peters Solange, Stahel Rolf |
| Synergistic polymorphic interactions of phase II metabolizing genes and their association toward lung cancer susceptibility in North Indians. International journal of environmental health research 2022 Oct 1-24. Walia Harleen Kaur, Sharma Parul, Singh Navneet, Sharma Siddhar |
| Development and validation of a polygenic hazard score to predict prognosis and adjuvant chemotherapy benefit in early-stage non-small cell lung cancer. Translational lung cancer research 2022 Sep 11 (9): 1809-1822. Li Dan-Hua, He Yong-Qiao, Wang Tong-Min, Xue Wen-Qiong, Deng Chang-Mi, Yang Da-Wei, Zhang Wen-Li, Wu Zi-Yi, Cao Lian-Jing, Dong Si-Qi, Jia Yi-Jing, Yuan Lei-Lei, Luo Lu-Ting, Wu Yan-Xia, Tong Xia-Ting, Zhang Jiang-Bo, Zheng Mei-Qi, Zhou Ting, Zheng Xiao-Hui, Li Xi-Zhao, Zhang Pei-Fen, Zhang Shao-Dan, Hu Ye-Zhu, Cao Xun, Wang Xin, Jia Wei-H |
| The UGT1A9*22 genotype identifies a high-risk group for irinotecan toxicity among gastric cancer patients. Genomics & informatics 2022 Sep 20 (3): e29. Lee Choong-Kun, Chon Hong Jae, Kwon Woo Sun, Ban Hyo-Jeong, Kim Sang Cheol, Kim Hyunwook, Jeung Hei-Cheul, Chung Jimyung, Rha Sun You |
| Tumoral PD-L1 does not impact time to treatment discontinuation in EGFR mutated non-small cell lung cancer patients treated with EGFR tyrosine kinase inhibitor-a Danish cohort study. Translational lung cancer research 2022 Sep 11 (9): 1796-1808. Dissing Julie Gabe, Ulhøi Maiken Parm, Sorensen Boe Sandahl, Meldgaard Pet |
| Whole-genome sequencing of East Asian lung cancers reveals new germline pathogenic variants. Cancer cell 2022 Sep . Mukherjee Semanti, Carrot-Zhang Ji |
| The miR-196a SNP Rs11614913 but not the miR-499 rs37464444 SNP is a Risk Factor for Non-small Cell Lung Cancer in an Iranian Population. Tanaffos 2022 Jan 21 (1): 15-23. Dezfuli Neda K, Adcock Ian M, Alipoor Shamila D, Salimi Babak, Seifi Sharareh, Chehrazi Mohammad, Varahram Mohammad, Mortaz Esmae |
| Analytical and clinical validation of a custom 15-gene next-generation sequencing panel for the evaluation of circulating tumor DNA mutations in patients with advanced non-small-cell lung cancer. PloS one 2022 17 (10): e0276161. Chow Yock Ping, Zainul Abidin Norziha, Kow Ken Siong, Tho Lye Mun, Wong Chieh L |
| Epidemiological evidence for associations between variants in CHRNA genes and risk of lung cancer and chronic obstructive pulmonary disease. Frontiers in oncology 2022 12 1001864. Yang Lei, Yang Zelin, Zuo Chunjian, Lv Xiaolong, Liu Tianyu, Jia Chenhao, Chen Huanw |
| First-line therapeutic strategy for patients with advanced non-small cell lung cancer with Leu858Arg epidermal growth factor receptor mutations: a Bayesian network meta-analysis. Therapeutic advances in chronic disease 2022 10 13 20406223221125706. Chen Chongxiang, Zhang Chunning, Lin Huaming, Liu Qianyin, Wu Limian, Zhou Chengzhi, Zhang Jiex |
| Genomic landscape of lung adenocarcinomas in different races. Frontiers in oncology 2022 12 946625. Shi Huashan, Seegobin Karan, Heng Fei, Zhou Kexun, Chen Ruqin, Qin Hong, Manochakian Rami, Zhao Yujie, Lou Yany |
| Genomic landscape of lung cancer in the young. Frontiers in oncology 2022 12 910117. Ruiz Rossana, Galvez-Nino Marco, Roque Katia, Montes Jaime, Nuñez Maria, Raez Luis, Sánchez-Gambetta Sergio, Jaúregui Sandra, Viale Sandra, Smith Edward S, Pinto Joseph A, Mas Lu |
| Takotsubo cardiomyopathy Afatinib-related in a non-small cell lung cancer patient: Case report. Frontiers in cardiovascular medicine 2022 9 1060813. Ramos German E, Caglevic Christian, Bulnes Juan F, Panay Sergio E, Zapata Mario I, Daniele Andrés J, Rodríguez Manuel |
| The Roles of EXO1 and RPA1 Polymorphisms in Prognosis of Lung Cancer Patients Treated with Platinum-Based Chemotherapy. Disease markers 2022 2022 3306189. He Jia, Wang Zhan, Wang Ying, Zou Ting, Li Xiang-Ping, Chen Ju |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 01, 2023
- Content source: